Lonoctocog alfa Uses, Dosage, Side Effects and more

Antihemophilic Factor binds factor IXa along with calcium and phospholipid, This complex converts factor X to factor Xa to facilitate clotting cascade.

Trade Name	Lonoctocog alfa
Generic	Lonoctocog alfa
Lonoctocog alfa Other Names	Lonoctocog alfa
Type
Groups	Approved, Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Uses

Lonoctocog alfa is a recombinant Factor VIII used to treat hemophilia A to control bleeding.

For the treatment of hemophilia A, von Willebrand disease and Factor XIII deficiency.

Lonoctocog alfa is also used to associated treatment for these conditions: Bleeding

How Lonoctocog alfa works

Antihemophilic factor (AHF) is a protein found in normal plasma which is necessary for clot formation. The administration of AHF provides an increase in plasma levels of AHF and can temporarily correct the coagulation defect of patients with hemophilia A (classical hemophilia).